Literature DB >> 26615534

Incidence of delayed ipsilateral intraparenchymal hemorrhage after stent-assisted coiling of intracranial aneurysms in a high-volume single center.

Yasha Kayan1, Josser E Delgado Almandoz2, Jennifer L Fease2, Kira Tran2, Anna M Milner2, Jill M Scholz2.   

Abstract

INTRODUCTION: Delayed ipsilateral intraparenchymal hemorrhage (IPH) has been reported following technically successful treatment of intracranial aneurysms using flow-diverting stents in up to 8.5% of patients. We report a similar, though less frequent phenomenon in the setting of stent-assisted coil embolization.
METHODS: Institutional review board approval was obtained. A retrospective analysis of a prospective neurointerventional procedure registry was performed to review all IPHs that occurred in aneurysm patients within 90 days of endovascular treatment performed between November 2002 and November 2014 at one institution. Age, sex, hypertension, dual antiplatelet therapy, and technical details of the procedure were recorded.
RESULTS: A total of 1697 patients underwent endovascular treatment of an intracranial aneurysm without a flow diverter at our institution during the study period. Among these, 138 patients underwent stent-assisted coiling (8.1%). Of these, three patients (2.2%) suffered a delayed IPH within the vascular territory distal to the treated lesion (one woman, median age 60 years).
CONCLUSIONS: Recently described in the setting of flow diversion, delayed ipsilateral IPH is not limited to flow-diverting stents. Though less frequent, a potential for this complication may exist following any intracranial stenting procedure, possibly related to hemorrhagic conversion of microembolic phenomena in the setting of dual antiplatelet or anticoagulation therapy.

Entities:  

Keywords:  Aneurysm; Complication; Hemorrhage; Intervention; Stent

Mesh:

Year:  2015        PMID: 26615534     DOI: 10.1007/s00234-015-1624-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  19 in total

1.  Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms.

Authors:  J P Cruz; M Chow; C O'Kelly; B Marotta; J Spears; W Montanera; D Fiorella; T Marotta
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

2.  Silent thromboembolic events associated with the treatment of unruptured cerebral aneurysms by use of Guglielmi detachable coils: prospective study applying diffusion-weighted imaging.

Authors:  G Rordorf; R J Bellon; R E Budzik; J Farkas; G F Reinking; R S Pergolizzi; M Ezzeddine; A M Norbash; R G Gonzalez; C M Putman
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

3.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

Authors:  Yongjun Wang; Yilong Wang; Xingquan Zhao; Liping Liu; David Wang; Chunxue Wang; Chen Wang; Hao Li; Xia Meng; Liying Cui; Jianping Jia; Qiang Dong; Anding Xu; Jinsheng Zeng; Yansheng Li; Zhimin Wang; Haiqin Xia; S Claiborne Johnston
Journal:  N Engl J Med       Date:  2013-06-26       Impact factor: 91.245

4.  Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results.

Authors:  I Saatci; K Yavuz; C Ozer; S Geyik; H S Cekirge
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

5.  Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device.

Authors:  I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

6.  Thromboembolic events associated with endovascular treatment of cerebral aneurysms.

Authors:  Tamer Altay; Hee I Kang; Henry H Woo; Thomas J Masaryk; Peter A Rasmussen; David J Fiorella; Shaye I Moskowitz
Journal:  J Neurointerv Surg       Date:  2011-01-08       Impact factor: 5.836

7.  Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: complications, procedural results, MR findings and clinical outcome.

Authors:  M Cronqvist; R Wirestam; B Ramgren; L Brandt; O Nilsson; H Säveland; S Holtås; E-M Larsson
Journal:  Neuroradiology       Date:  2005-10-19       Impact factor: 2.804

8.  Comparison of Enterprise with Neuroform stent-assisted coiling of intracranial aneurysms.

Authors:  Yasha Kadkhodayan; Nicholas Rhodes; Spiros Blackburn; Colin P Derdeyn; DeWitte T Cross; Christopher J Moran
Journal:  AJR Am J Roentgenol       Date:  2013-04       Impact factor: 3.959

9.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

Authors:  Hans-Christoph Diener; Julien Bogousslavsky; Lawrence M Brass; Claudio Cimminiello; Laszlo Csiba; Markku Kaste; Didier Leys; Jordi Matias-Guiu; Hans-Jürgen Rupprecht
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

10.  Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience.

Authors:  Pedro Lylyk; Carlos Miranda; Rosana Ceratto; Angel Ferrario; Esteban Scrivano; Hugh Ramirez Luna; Aaron L Berez; Quang Tran; Peter K Nelson; David Fiorella
Journal:  Neurosurgery       Date:  2009-04       Impact factor: 4.654

View more
  7 in total

1.  Factors associated with the new appearance of cerebral microbleeds after endovascular treatment for unruptured intracranial aneurysms.

Authors:  Eiji Higashi; Taketo Hatano; Mitsushige Ando; Hideo Chihara; Takenori Ogura; Keita Suzuki; Keitaro Yamagami; Daisuke Kondo; Takahiko Kamata; Shota Sakai; Hiroki Sakamoto; Izumi Nagata
Journal:  Neuroradiology       Date:  2021-01-07       Impact factor: 2.804

2.  Changes in contrast transit times on digital subtraction angiography post-Pipeline Embolization Device deployment.

Authors:  Ahmed E Hussein; Andreas Linninger; Sophia F Shakur; Fady T Charbel; Chih-Yang Hsu; Fady T Charbel; Ali Alaraj
Journal:  Interv Neuroradiol       Date:  2017-01-17       Impact factor: 1.610

3.  Aneurysm size and the Windkessel effect: An analysis of contrast intensity in digital subtraction angiography.

Authors:  Ahmed E Hussein; Darian R Esfahani; Andreas Linninger; Fady T Charbel; Chih-Yang Hsu; Fady T Charbel; Ali Alaraj
Journal:  Interv Neuroradiol       Date:  2017-04-26       Impact factor: 1.610

4.  The profile of blunt traumatic infratentorial cranial bleed types.

Authors:  Isaac Ng; Nikolay Bugaev; Ron Riesenburger; Aaron C Shpiner; Janis L Breeze; Sandra S Arabian; Reuven Rabinovici
Journal:  J Clin Neurosci       Date:  2018-10-17       Impact factor: 1.961

5.  Clinical and angiographic outcomes in patients with intracranial aneurysms treated with the pipeline embolization device: intra-procedural technical difficulties, major morbidity, and neurological mortality decrease significantly with increased operator experience in device deployment and patient management.

Authors:  Josser E Delgado Almandoz; Yasha Kayan; Andrea Tenreiro; Adam N Wallace; Jill M Scholz; Jennifer L Fease; Anna M Milner; Maximilian Mulder; Kyle M Uittenbogaard; Oscar Tenreiro-Picón
Journal:  Neuroradiology       Date:  2017-10-06       Impact factor: 2.804

6.  Does Systemic Lupus Erythematosus Increase the Risk of Procedure-Related Complication in Endovascular Treatment of Intracranial Aneurysm?

Authors:  Jung Hwan Lee; Sang Weon Lee; Chang Hwa Choi; Jun Kyeung Ko
Journal:  Yonsei Med J       Date:  2020-05       Impact factor: 2.759

7.  Endovascular Treatment of Posterior Circulation Saccular Aneurysms With the p64 Flow Modulation Device: Mid-and Long-Term Results in 54 Aneurysms From a Single Center.

Authors:  Victoria Hellstern; Marta Aguilar-Pérez; Elina Henkes; Carmen Serna-Candel; Christina Wendl; Hansjörg Bäzner; Oliver Ganslandt; Hans Henkes
Journal:  Front Neurol       Date:  2021-07-16       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.